EU for Health 2021-2027 — A vision for a healthier European Union
The EU for Health program is the EU’s ambitious response to COVID-19. The pandemic has serious consequences for patients, medical and healthcare personnel and European healthcare systems. The new EU for Health program goes beyond crisis response to address the resilience of health systems.
The EU for Health programme, created by Regulation (EU) 2021/522, will fund eligible entities, health organizations and NGOs from EU countries or third countries associated with the programme.
Areas of expertise
With the EU for Health programme, the EU will invest 5.3 billion euros at current prices in actions with added value at European level, complementing the policies of EU countries and pursuing one or several objectives of the programme:
The 10 specific objectives subordinate to the four general goals are:Improve and promote health in the Union:prevent disease and promote health,international initiatives in the field of health and cooperation.
Responding to cross-border health threats:prevent, prepare and respond to cross-border health threats,complement national reserves of essential essential products in crisis situations,create a pool of medical personnel, other health professionals and support staff.
Improving drugs, medical devices and important products in crisis situations:make medicines, medical devices and important products available in crisis situations at affordable prices.
Strengthen health systems, their resilience and resource efficiency:consolidate health data, digital tools and services and the digital transformation of health care,improve access to healthcare,draft and implement EU health legislation and take informed decisions,work in an integrated manner in national health systems.
The EU for Health program will pave the way for a European Health Union by investing in key health priorities:Responding to the COVID-19 crisis and strengthening the EU’s resilience to cross-border health threats
Adoption of the European Plan to Fight Cancer anPharmaceutical Strategy for EuropeWe will also intensify our work in other areas, such as digitizing health systems, reducing the number of infections resistant to antimicrobial agents and improving vaccination rates.
The EU will expand successful initiatives such as the European Reference Networks for Rare Diseases and continue international cooperation on global health threats and challenges.intervening parties
Implementing the EU Program for Health involves the participation of many actors:
EU countries are consulted on the priorities and strategic orientations of the program and work together with the Commission within the ‘EU Steering Group for Health’ to ensure coherence and complementarity with national health policies. They give their opinion in the framework of the EU Health Program Committee, before the adoption of the annual work programmes.
Stakeholders, for example representatives of civil society and patient associations, academics and health professional organisations, provide input on priorities and strategic directions, as well as on what the annual work program should focus on.
The European Parliament is kept informed of developments in the preparatory work and awareness-raising activities carried out with stakeholders.The European Commission prepares, adopts and implements the annual work programs and monitors and reports on the progress made in meeting the program objectives.
In addition, the Commission may request the opinion of the competent decentralized agencies and independent experts in the field of health on technical or scientific matters relevant to the implementation of the programme.It is up to the European Health and Digital Executive Agency (HADEA) to implement the programme.
The EU Program for Health is implemented through annual work programmes. The work program for 2021See this link in another language••• has been adopted (attached). The planned measures have four strands: disease prevention, preparedness for crisis situations, health systems and digitalisation, with a transversal focus on cancer.